he company released the following statement, "MultiCorp International, Inc. is excited to announce that Mr. David Gustafson has taken over the helm of
Chief Executive Officer of the company on an interim basis. The current CEO, Mr. Paul D. Lisenby, is taking a leave of absence due to medical reasons.
There is no timetable for his return. In the meantime, we welcome Mr. Gustafson aboard as our CEO to spearhead the efforts of the company in the further
development of the patented migraine medicine